CAR-T equally safe, effective for older patients with advanced multiple myeloma February 24, 2021 3 min read Source/Disclosures Published by: Source: Berdeja J, et al. Abstract 486. Presented at: The 2021 TCT Meetings Digital Experience (virtual meeting); Feb. 8-12, 2021. Disclosures: Bristol Myers Squibb and bluebird bio sponsored the study. Berdeja reports consultant roles with […]

Genmab Publishes 2020 Annual Report Company Announcement Copenhagen, Denmark; February 23, 2021 – Genmab A/S (Nasdaq: GMAB) announced today the publication of its Annual Report for 2020. Below is a summary of business progress in 2020, financial performance for the year and the financial outlook for 2021. The full report is attached as a PDF […]

Pursue 8 E (Uploaded): Nephropathology- Plasma cell Dyscrasia. Nephropathology Plasma cell Dyscrasia. Lecture conducted by: Dr. Suvradeep Mitra MD. (PGIMER- Chandigarh), DM- Histopathology (PGIMER- Chandigarh) PDCC (ICP) in Renal and Transplant Pathology (PGIMER, Chandigarh). Asst Professor in the Dept of Pathology and Lab Medicine, AIIMS, Bhubaneswar More than 70 publications in indexed National and International […]

PET-CT vs MRI in multiple myeloma Philippe Moreau, MD from the University Hospital of Nantes, Nantes, France gives an overview of a prospective comparative study on PET-CT and MRI in multiple myeloma (MM). The primary endpoint of the trial (NCT01309334) was to compare MRI and PET-CT in regard to the number of bone lesions at […]

Xpovio Open to Advanced Myeloma Patients Outside US via Access Program People with advanced multiple myeloma and diffuse large B-cell lymphoma (DLBCL) will soon be able to access Xpovio (selinexor) outside the U.S. through a managed access program. This program, also known as a named patient program, allows patients and doctors in countries where a medicine is […]

Fate Therapeutics (FATE) to Release Quarterly Earnings on Wednesday Fate Therapeutics (NASDAQ:FATE) is set to issue its quarterly earnings data after the market closes on Wednesday, February 24th. Analysts expect the company to announce earnings of ($0.38) per share for the quarter. Shares of FATE stock opened at $110.18 on Friday. The stock has a […]

RCSI’s new Pathology Chair reveals hi-tech vision Prof Siobhan Glavey enthused by latest developments in cancer diagnostics and precision medicine The new Chair and Professor in the Department of Pathology at the RCSI University of Medicine and Health Sciences has vowed to help her students become “healthcare experts of the future” by giving them access […]

Dr Tony Holohan’s wife Emer dies following long battle with illness DR TONY Holohan’s wife, Emer, has died following a long battle with illness.  Tributes have flooded in for Dr Emer, who passed away at Our Lady’s Hospice in Harold’s Cross, Dublin.  A beloved wife and mother of two, she was previously diagnosed with multiple myeloma, […]

Actress Tamannaah’s pledge to help Devika ‘Fightagainstcancer’ with Tring Mumbai (Maharashtra) [India], February 19 (ANI/NewsVoir): With a call for the generous hearts to step ahead and contribute, Tamannaah has associated with Tring’s Icons for Change initiative to support a cause that is extremely close to her heart. The actress went live to garner donations for […]

Novel Additions Require Nuanced Treatment Selection in Relapsed/Refractory Myeloma Knowledge of prior therapies a patient has received, adequate prophylactic treatment, and consistent monitoring for unique toxicities is necessary to ensure patients are able to derive optimal benefit from novel options that have explored in relapsed/refractory myeloma therapy, according to Parameswaran Hari, MD, MRCP. “My approach […]